<DOC>
	<DOCNO>NCT02493179</DOCNO>
	<brief_summary>The purpose study examine efficacy dose regimen serratiopeptidase ( serodase 5 mg ) prospective , randomize , parallel , double blind Placebo- control study .</brief_summary>
	<brief_title>Efficacy Evaluation ( Serodase 5 mg Tablet ) Treatment Inflammation After Third Molar Surgery</brief_title>
	<detailed_description>A prospective , randomize , parallel , double blind Placebo- control study examine efficacy dose regimen serratiopeptidase ( serodase 5 mg ) 112 male females volunteer treatment inflammation third molar surgery , compare drug treatment v placebo period 20 week To assess dose effectiveness dose regimen Serodase 5 mg ; primary outcome trismus swell inflammation secondary outcome.the expect duration participant participation around 5 day divide 4 visit , time point measurment ( 0,2,4 5 day ) . The result expect assess improvement maximal interincisal distance , reduction swell improvment sensation post-operative pain .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Trismus</mesh_term>
	<mesh_term>Serratiopeptidase</mesh_term>
	<criteria>participant present impacted low wisdom tooth need Buccaneers flap buccal distal bone removal . male female 1850 participant willing able give inform consent paricipation study . Able willing able study requirments . oral surgical procedure session except removal supernumerary third molar . female subject pregnant lactating subject participate clinical research study within previous 8 week . subject anti coagulant drug . Unwilling participant continue study abnormality wound heal process .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>